Departing Andrew Witty has been wise with GlaxoSmithKline. Neil Woodford is making the erroneous call hereGlaxoSmithKline must be addicted to exciting succession scraps. Back in 2007,when the now departing Sir Andrew Witty landed the chief executive’s job, the affair was long and bloody. Three internal contenders were invited to pitch their ideas in a semi-public shoot-out. Witty, or the youngest and most junior executive,won and the disappointed duo wouldn’t stay for adore nor share options. They departed within months.
It was a bracing experience and not one you’d think GSK would wish to repeat. There is every chance it will. Witty won’t leave until next March, which creates plenty of time for plots, and intrigue and manoeuvring. Related: GSK chief Andrew Witty to leave drugmaker Related: The Albanese years at Rio Tinto: a squandered opportunity Continue reading...
Source: theguardian.com